Suppliers / Dr. Pfleger Arzneimittel

Dr. Pfleger Arzneimittel

Germany 192 employees Updated 9 July 2026

Dr. Pfleger Arzneimittel is an API and finished-dose manufacturer based in Germany. It holds one valid CEP. Its filings concentrate with EMA, MPA (SE) and ARCSA (EC). Its GMP standing is certified by ZLG (DE), ANVISA (Brazil) and EMA.

active US DMFs

valid CEPs

registered plants

filings across 8 regulators

These figures were checked against the regulators' own files on 25 July 2026

EU GMP

1 of 1 confirmed

Sources: EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Registered plants

Site	FDA FEI
BAMBERG, Germany	Not on file

What they file, and where

Molecule	Regulators	Docs
Trospium Chloride	EDQM	1

Also appears on these molecule pages

Adapalene finished dose Methenamine finished dose Methionine finished dose Terazosin finished dose Trospium API

Filings and GMP by regulator

Regulator	Filings	GMP certificates
EMA	33	1
MPA (SE)	2	None
ARCSA (EC)	2	None
INVIMA (CO)	2	None
UZPHARM (UZ)	2	None
DMP (NO)	1	None
ZLG (DE)	None	6
ANVISA (Brazil)	None	1

Comparing suppliers?

Choose your molecules and target markets. Dr. Pfleger Arzneimittel comes back tiered against every other supplier able to file there.

Start for free

No sales call.

Sources on this page

FDA: Drug master files, establishment registration, inspection classifications
EDQM: Certificates of suitability
EudraGMDP and national regulators: GMP certificates